PubMed:20711231 / 617-855 JSONTXT

Annnotations TAB JSON ListView MergeView

    PubMed_ArguminSci

    {"project":"PubMed_ArguminSci","denotations":[{"id":"T6","span":{"begin":0,"end":238},"obj":"DRI_Outcome"}],"text":"In this study, we asked if ErbB2 expression correlates with Pak1 and Erk activity in human breast cancer specimens, and if Pak1 signaling is required for ErbB2 transformation in a three-dimensional (3D) in vitro setting and in xenografts."}

    PubmedHPO

    {"project":"PubmedHPO","denotations":[{"id":"T5","span":{"begin":91,"end":104},"obj":"HP_0003002"},{"id":"T6","span":{"begin":91,"end":104},"obj":"HP_0100013"},{"id":"T7","span":{"begin":98,"end":104},"obj":"HP_0002664"}],"text":"In this study, we asked if ErbB2 expression correlates with Pak1 and Erk activity in human breast cancer specimens, and if Pak1 signaling is required for ErbB2 transformation in a three-dimensional (3D) in vitro setting and in xenografts."}

    DisGeNET5_gene_disease

    {"project":"DisGeNET5_gene_disease","denotations":[{"id":"20711231-4#60#64#gene5058","span":{"begin":60,"end":64},"obj":"gene5058"},{"id":"20711231-4#91#104#diseaseC0006142","span":{"begin":91,"end":104},"obj":"diseaseC0006142"},{"id":"20711231-4#91#104#diseaseC0678222","span":{"begin":91,"end":104},"obj":"diseaseC0678222"}],"relations":[{"id":"60#64#gene505891#104#diseaseC0006142","pred":"associated_with","subj":"20711231-4#60#64#gene5058","obj":"20711231-4#91#104#diseaseC0006142"},{"id":"60#64#gene505891#104#diseaseC0678222","pred":"associated_with","subj":"20711231-4#60#64#gene5058","obj":"20711231-4#91#104#diseaseC0678222"}],"text":"In this study, we asked if ErbB2 expression correlates with Pak1 and Erk activity in human breast cancer specimens, and if Pak1 signaling is required for ErbB2 transformation in a three-dimensional (3D) in vitro setting and in xenografts."}